BPA call 24F28001 pimc, anavorx distribution LLC, anascorp injections, IHS1489441
Ended Awarded Last action
- Contract number
- 75H71224F28001
- Awardee
-
Rare Disease Therapeutics, Inc. UEI M7B1ABSZJKX8
- Awarding agency
-
Indian Health Service
Department of Health and Human Services
- Obligated
- $0
Award facts
- Contract value
- $0.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Phoenix, AZ 85016, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$45,530 | |
| Original award | $45,530 |
About this award
The Department of Health and Human Services' Indian Health Service has awarded a Blanket Purchase Agreement (BPA) call to Rare Disease Therapeutics, Inc., a woman-owned small business specializing in the provision of specialty pharmaceuticals and orphan drugs to the federal government. The BPA call, valued at $45,530.20, is for the delivery of ANASCORP, a scorpion antivenom injection, to IHS clinics serving tribal nations in locations such as Phoenix and Whiteriver, Arizona. This BPA call is issued against Rare Disease Therapeutics' GSA Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB) and has a performance period through April 2025. Rare Disease Therapeutics holds two significant federal contract Indefinite Delivery Vehicles (IDVs): a $250,000 BPA with the Department of Veterans Affairs National Acquisition Center and a $393,849 BPA with the Indian Health Service, both of which leverage the company's GSA Schedule contract to provide access to its catalog of specialty pharmaceutical products, particularly orphan drugs for rare diseases.
Quick answers
Who was awarded contract 75H71224F28001?
75H71224F28001 was awarded to Rare Disease Therapeutics, Inc. by Indian Health Service (Department of Health and Human Services) on July 19, 2024.
How much is contract 75H71224F28001 worth?
The government has obligated $0 on 75H71224F28001.
Is contract 75H71224F28001 an order under another contract?
Yes. 75H71224F28001 is a BPA call under 36F79718D0404-75H71224A00013, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 75H71224F28001 competed?
The extent of competition for 75H71224F28001 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award